Evogen Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 6

Evogen General Information

Description

Developer of molecular diagnostics systems designed to offer cost-effective technologies that analyze biothreat rapidly and accurately. The company's systems capture the widest range of bioaerosols, particulate matter and soluble vapours and provide systems for biodefense, clinical, research, animal health, food and water safety, indoor air quality, environmental monitoring and forensics markets, enabling users to address unmet medical needs and reduce the long-term growth of health care costs.

Contact Information

Website
www.evogen.com
Formerly Known As
Sceptor Industries
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 727 Norristown Road, Building 3
  • Suite 104
  • Lower Gwynedd, PA 19002
  • United States
+1 (913)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Healthcare Technology Systems
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 727 Norristown Road, Building 3
  • Suite 104
  • Lower Gwynedd, PA 19002
  • United States
+1 (913)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Evogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 01-Jul-2022 Completed Generating Revenue
8. Grant 24-Feb-2020 Completed Generating Revenue
7. Accelerator/Incubator 01-Feb-2020 Completed Generating Revenue
6. Grant 30-Sep-2019 Completed Generating Revenue
5. Later Stage VC 19-Feb-2014 Completed Generating Revenue
4. Debt - General 20-Jan-2010 Completed Generating Revenue
3. Later Stage VC (Series B) 17-Nov-2008 Completed Generating Revenue
2. Early Stage VC (Series A) 04-Apr-2002 $1.5M $1.5M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Evogen’s complete valuation and funding history, request access »

Evogen Patents

  • 39

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Evogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210199672-A1 Biomarkers and methods for evaluation and treatment of epileptic vs non-epileptic seizures / no seizures / psychogenic non-epileptic seizures Pending 29-May-2018
US-20220178948-A1 Biomarkers and methods for detection of seizures and epilepsy Active 16-May-2017
US-20200299377-A1 Biomarkers and methods for detection of seizures and epilepsy Active 16-May-2017
US-11692030-B2 Biomarkers and methods for detection of seizures and epilepsy Active 16-May-2017
US-20240151733-A1 Biomarkers and methods for detection of seizures and epilepsy Pending 16-May-2017 G01N33/6896
To view Evogen’s complete patent history, request access »

Evogen Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
MRIGlobal Corporation Minority
EaglePicher Pharmaceutical Services Corporation Minority
JHW Greentree Capital PE/Buyout Minority
Shalom Equity Fund Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Evogen Acquisitions (1)

Evogen’s most recent deal was a Merger/Acquisition with Cognizance Biomarkers. The deal was made on 01-Jan-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cognizance Biomarkers 01-Jan-2015 Merger/Acquisition Biotechnology
To view Evogen’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Evogen FAQs

  • When was Evogen founded?

    Evogen was founded in 2001.

  • Where is Evogen headquartered?

    Evogen is headquartered in Lower Gwynedd, PA.

  • What industry is Evogen in?

    Evogen’s primary industry is Biotechnology.

  • Is Evogen a private or public company?

    Evogen is a Private company.

  • What is Evogen’s current revenue?

    The current revenue for Evogen is .

  • How much funding has Evogen raised over time?

    Evogen has raised $6.39M.

  • Who are Evogen’s investors?

    National Institutes of Health, MRIGlobal, EaglePicher Pharmaceutical Services, JHW Greentree Capital, and Shalom Equity Fund are 5 of 6 investors who have invested in Evogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »